Company research
Revance Therapeutics, Inc.
CIK 1479290Updated Nov 16, 2026
Securities
Historical securities (1)
RVNC · NASDAQ · equity · closed Feb 6, 2025RVNC price & chart
Historical security
This listing closed Feb 6, 2025. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
SCHEDULE 13G/A - filed by Beryl Capital Management LLC regarding Revance Therapeutics, Inc.
SCHEDULE 13G/A - filed by JPMORGAN CHASE & CO regarding Revance Therapeutics, Inc.
15-12G filing
SCHEDULE 13G/A - filed by Palo Alto Investors LP regarding Revance Therapeutics, Inc.
S-8 POS filing
Show 5 more recent filings
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 478,454,000Source | 581,900,000Source | 531,163,000Source | 720,220,000Source |
| Property, Plant and Equipment, NetUSD | 17,225,000Source | 22,139,000Source | 24,661,000Source | 17,499,000Source |
| GoodwillUSD | 0Source | 77,175,000Source | 146,964,000Source | 146,964,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 9,808,000Source | 27,004,000Source | 55,334,000Source | 71,343,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 137,329,000Source | 108,965,000Source | 110,623,000Source | 333,558,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 27,676,000Source | 11,339,000Source | 3,348,000Source | 1,829,000Source |
| Inventory, NetUSD | 45,579,000Source | 18,325,000Source | 10,154,000Source | 5,876,000Source |
| Assets, CurrentUSD | 338,865,000Source | 374,727,000Source | 246,117,000Source | 450,003,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 11,145,000Source | 4,356,000Source | 7,544,000Source | 5,793,000Source |
| Operating Lease, Right-of-Use AssetUSD | 53,167,000Source | 39,223,000Source | 44,340,000Source | 29,632,000Source |
| Other Assets, NoncurrentUSD | 321,000Source | 1,687,000Source | 8,701,000Source | 1,334,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 630,058,000Source | 569,300,000Source | 462,692,000Source | 345,930,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 88,000Source | 82,000Source | 72,000Source | 69,000Source |
| Retained Earnings (Accumulated Deficit)USD | -2,078,360,000Source | -1,754,374,000Source | -1,397,952,000Source | -1,126,293,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 14,000Source | -374,000Source | -18,000Source | 0Source |
| Stockholders' Equity Attributable to ParentUSD | -151,604,000Source | 12,600,000Source | 68,471,000Source | 374,290,000Source |
| Additional Paid in Capital, Common StockUSD | 1,926,654,000Source | 1,767,266,000Source | 1,466,369,000Source | 1,500,514,000Source |
| Liabilities and EquityUSD | 478,454,000Source | 581,900,000Source | 531,163,000Source | 720,220,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 89,224,000Source | 75,682,000Source | 67,289,000Source | 60,964,000Source |
| Operating Lease, Liability, CurrentUSD | 5,703,000Source | 4,243,000Source | 4,746,000Source | 4,437,000Source |
| Accounts Payable, CurrentUSD | 13,809,000Source | 4,546,000Source | 10,603,000Source | 12,657,000Source |
| Operating Lease, Liability, NoncurrentUSD | 40,985,000Source | 34,182,000Source | 39,131,000Source | 27,146,000Source |
| Other Liabilities, NoncurrentUSD | 2,835,000Source | 1,485,000Source | 1,485,000Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 53,824,000Source | 59,357,000Source | 39,558,000Source | 32,938,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 253,900,000Source | 340,700,000Source | 225,100,000Source | 436,500,000Source |
| Deferred Tax Liabilities, NetUSD | 18,553,000Source | 11,644,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | — | 379,374,000Source | — | — |
| Long-term Debt, Current MaturitiesUSD | 2,500,000Source | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 426,595,000Source | — | — | — |
| Short-term InvestmentsUSD | 116,586,000Source | 231,742,000Source | 114,448,000Source | 102,947,000Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 11,375,000Source | 33,732,000Source | 19,853,000Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 47,813,000Source | 52,340,000Source | 43,434,000Source | 36,453,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 16,338,000Source | 7,990,000Source | 1,519,000Source | 1,736,000Source |
| Increase (Decrease) in InventoriesUSD | 14,910,000Source | 6,008,000Source | 4,278,000Source | 5,876,000Source |
| Increase (Decrease) in Accounts PayableUSD | 6,900,000Source | -5,448,000Source | -1,824,000Source | 4,425,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | 0Source | 0Source | -2,720,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -216,575,000Source | -193,548,000Source | -221,538,000Source | -178,502,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 109,740,000Source | -138,798,000Source | -29,665,000Source | 12,131,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 6,886,000Source | 3,210,000Source | 10,375,000Source | 259,304,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 8,216,000Source | 6,496,000Source | — | 8,441,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 136,567,000Source | 331,694,000Source | 29,869,000Source | 331,484,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 0Source | 348,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 144,749,000Source | 115,017,000Source | 115,669,000Source | 337,003,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 15,090,000Source | 12,231,000Source | 5,031,000Source | 2,530,000Source |
| Additional Financial Items | ||||
| AmortizationUSD | 9,411,000Source | — | — | — |
| Share-based Payment Arrangement, ExpenseUSD | 49,187,000Source | 52,340,000Source | 43,434,000Source | 36,453,000Source |
| Amortization of Debt Issuance CostsUSD | 1,791,000Source | 1,662,000Source | 1,250,000Source | 333,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 2,397,000Source | 1,880,000Source | 1,250,000Source | 10,726,000Source |
| Amortization of Intangible AssetsUSD | 6,130,000Source | 28,331,000Source | 16,008,000Source | 7,200,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 253,900,000Source | 340,700,000Source | 225,100,000Source | 436,500,000Source |
| DepreciationUSD | — | — | — | 10,250,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | -52,000Source |
| GoodwillUSD | 0Source | 77,175,000Source | 146,964,000Source | 146,964,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | 16,000,000Source | — | — | — |
| Goodwill, Impairment LossUSD | 77,175,000Source | 69,789,000Source | 0Source | — |
| Impairment of Intangible Assets, Finite-livedUSD | 16,007,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 300,000Source | 700,000Source | 0Source | -2,620,000Source |
| Net Income (Loss) Attributable to ParentUSD | -323,986,000Source | -356,422,000Source | -281,310,000Source | -282,089,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -323,986,000Source | -356,422,000Source | -281,310,000Source | — |
| Operating Costs and ExpensesUSD | 550,817,000Source | 474,523,000Source | 352,474,000Source | 288,487,000Source |
| Other Nonoperating Income (Expense)USD | -838,000Source | -2,181,000Source | -759,000Source | -592,000Source |
| Proceeds from Issuance of Common StockUSD | 100,183,000Source | 31,814,000Source | 21,706,000Source | 68,367,000Source |
| Proceeds from Stock Options ExercisedUSD | 15,289,000Source | 4,820,000Source | 16,688,000Source | 6,892,000Source |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | 52,331,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | 234,040,000Source | 132,565,000Source | 77,798,000Source | 15,325,000Source |
| Selling, General and Administrative ExpenseUSD | 297,732,000Source | 223,934,000Source | 198,821,000Source | 151,846,000Source |
| Operating Income (Loss)USD | -316,777,000Source | -341,958,000Source | -274,676,000Source | -273,162,000Source |
| Other Nonoperating Income (Expense)USD | -838,000Source | -2,181,000Source | -759,000Source | -592,000Source |
| Income Tax Expense (Benefit)USD | 300,000Source | 700,000Source | 0Source | -2,620,000Source |
| Net Income (Loss) Attributable to ParentUSD | -323,986,000Source | -356,422,000Source | -281,310,000Source | -282,089,000Source |
| Earnings Per Share, BasicUSD per share | -3.83Source | -4.9Source | -4.17Source | — |
| Earnings Per Share, DilutedUSD per share | -3.83Source | -4.9Source | -4.17Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 84,599,409Source | 72,713,340Source | 67,507,818Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 84,599,409Source | 72,713,340Source | 67,507,818Source | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 6,130,000Source | 28,331,000Source | 16,008,000Source | 7,200,000Source |
| Current Income Tax Expense (Benefit)USD | 300,000Source | 700,000Source | 0Source | 100,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 6,130,000Source | 27,847,000Source | — | — |
| Goodwill, Impairment LossUSD | 77,175,000Source | 69,789,000Source | 0Source | — |
| Income (Loss) Attributable to Parent, before TaxUSD | -323,686,000Source | -355,722,000Source | -281,310,000Source | -284,709,000Source |
| Interest ExpenseUSD | 19,356,000Source | 16,474,000Source | 6,273,000Source | 15,148,000Source |
| Interest Expense, DebtUSD | 17,534,000Source | 13,787,000Source | 6,281,000Source | 15,142,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -323,986,000Source | -356,422,000Source | -281,310,000Source | — |
| Operating Costs and ExpensesUSD | 550,817,000Source | 474,523,000Source | 352,474,000Source | 288,487,000Source |
| Research and Development ExpenseUSD | 79,410,000Source | 101,286,000Source | 116,255,000Source | 125,795,000Source |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | 52,331,000Source | — | — | — |